MedPath

VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease

Not Applicable
Recruiting
Conditions
Severe Aortic Valve Stenosis
Interventions
Other: Virtual Reality assisted information
Registration Number
NCT05552352
Lead Sponsor
Heinrich-Heine University, Duesseldorf
Brief Summary

This prospective, randomized-controlled multicenter study investigates whether virtual reality-assisted patient education in patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) can improve patient understanding and simulative orientation, thereby reducing postinterventional complications, resulting in significantly shorter length of stay.

Detailed Description

This prospective, randomized-controlled multicenter study investigates whether VR-assisted patient education in patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) can improve patient understanding and simulative orientation, thereby reducing postinterventional complications, resulting in significantly shorter length of stay. Disorientation, anxiety, and pain can lead to the development of delirium and, through complications, to prolonged hospital stays during elective procedures. Virtual reality can combine different learning modalities (auditory, visual, written, haptic) and improve patient understanding of the procedure through educational interventions. More detailed knowledge of the environment, the players, the procedure, and safety aspects will reduce anxiety and stress before and during the procedure and reduce complications during post-interventional care. As a result, length of stay should be reduced.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
300
Inclusion Criteria
  • High-grade aortic valve stenosis
  • Indication for elective transfemoral transcatheter aortic valve implantation under analgesia (TAVI)
  • Existing heart center decision
  • Age ≥ 18 years
  • Signed informed consent form
Exclusion Criteria
  • Surgery planned under general anesthesia
  • Language barrier
  • Severe hearing or vision impairment
  • Advanced dementia syndrome
  • Known seizure disorder (epilepsy)
  • Positive pregnancy test on inclusion and/or pregnancy is present
  • Court ordered placement in an institution
  • Any psychosocial condition that makes compliance with the protocol unlikely

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention ArmVirtual Reality assisted informationPatients in the intervention arm receive on the day before the implantation of the artificial aortic valve, a virtual reality assisted information. On the day of the implantation the patients are informed about the process via virtual reality assisted information.
Primary Outcome Measures
NameTimeMethod
Length of hospital stay in daysfrom start of hospitalizations until hospital leave up until day 360

Primary endpoint is the mean hospital stay in each group in days.

Secondary Outcome Measures
NameTimeMethod
Anxiety during the procedure as assessed by State-Trait-Anxiety-Inventory questionnaireduring procedure

Anxiety and psychological stress are common during elective procedures such as TAVI. Both are considered triggers and amplifiers of delirium. Patients are asked to quantify their anxiety before the procedure using State-Trait-Anxiety-Inventory with minimum outcome 10 and maximum outcome 80. Lesser outcome means more anxiety.

Major bleeding and minor bleeding during hospitalization.at hospital leave up to 360 days after procedure

Bleeding is a typical complication after cardio-vascular interventional procedures. Unawareness, disorientation, falls, and delirium favor the occurrence of bleeding. After hospital discharge, the occurrence of bleeding is recorded according to Valve Academic Research Consortium-2 consensus document (VARC), which is based on the bleeding academic research consortium (BARC) classification.

Survival / rehospitalization at 6 and 12 monthsafter 6 and 12 months after hospital leave

After 6 and 12 months patients are contacted and information is gathered about survival of the patients and possible rehospitalization events.

Anxiety during the procedure as assessed by visual analog scaleduring procedure

Anxiety and psychological stress are common during elective procedures such as TAVI. Both are considered triggers and amplifiers of delirium. Patients are asked to quantify their anxiety before the procedure using a visual analog scale ranging from 1 to 10.

Mental state on the day before the procedure as assessed by visual analog scale1 day before procedure

Anxiety and psychological stress are common before elective procedures such as TAVI. Both are considered triggers and amplifiers of delirium. Patients are asked to quantify their anxiety before the procedure using a visual analog scale ranging from 1 to 10.

Pain during the procedureduring procedure

Pain can occur despite analgesia during an elective procedure such as TAVI. Pain is considered a trigger and amplifier of delirium. Patients are asked to quantify their pain on a visual analog scale during the procedure (time point: procedure performed but still in the hybrid operating room). Here, 0 corresponds to no pain and 10 to the maximum imaginable pain.

Anxiety / stress before, during and after the procedure (amylase and cortisol in saliva).on the 1 day before, during and on day 1-3 after procedure

Patients will have saliva samples taken before, during and after the procedure. From these, the parameters cortisol and alpha-amylase are additionally determined on an optional basis within the scope of this study. Both parameters are considered established to quantify anxiety and stress especially intraindividually.

Maximum length of hospital stay, in daysat hospital leave up to 360 days after procedure

In addition to the mean hospital stay in days, a maximum hospital stay is also calculated.

Mental state on the day before the procedure as assessed by State-Trait-Anxiety-Inventory questionnaire1 day before procedure

Anxiety and psychological stress are common before elective procedures such as TAVI. Both are considered triggers and amplifiers of delirium. Patients are asked to quantify their anxiety before the procedure using State-Trait-Anxiety-Inventory with minimum outcome 10 and maximum outcome 80. Lesser outcome means more anxiety.

Mental state on the day before the procedure as assessed by Hospital Anxiety and Depression Scale German Version questionnaire1 day before procedure

Anxiety and psychological stress are common before elective procedures such as TAVI. Both are considered triggers and amplifiers of delirium. Patients are asked to quantify their anxiety before the procedure using Hospital Anxiety and Depression Scale German Version questionnaire. Anxiety scale in the questionnaire has values from 0 to 21 and Depression scale has values from 0 to 21. Lesser values denote less anxiety or depression.

Knowledge test after informed consent1 day before procedure after informed consent

In order to test to what extent the addition of a combination of different learning modalities (acoustic, visual, written, haptic) implemented in virtual reality to the medico-legal informed consent is superior to the standard informed consent, a survey is conducted after the informed consent.

Anxiety/stress before, during, and after surgery (measured as serum cortisol)on the 1 day before, during and on day 1-3 after procedure

Anxiety and psychological stress are common before and during elective procedures such as TAVI. Both are considered triggers and amplifiers of delirium. Patients will have routine blood samples taken before, during, and after the procedure. From these, the parameter cortisol in serum is additionally determined optionally in the context of this study. Serum cortisol is an established parameter to quantify anxiety and stress, especially intraindividually.

Trial Locations

Locations (1)

Universitätsklinikum Düsseldorf, Klinik für Kardiologie, Pneumologie & Angiologie

🇩🇪

Düsseldorf, NRW, Germany

© Copyright 2025. All Rights Reserved by MedPath